Dabur International and Dermoviva Skin Essentials, have been removed as a defendant in multiple lawsuits filed in a US court over allegations that their hair-relaxer products caused ovarian cancer, uterine cancer and other related health issues. However, lawsuits filed against its third international subsidiary Namaste Laboratories LLC, would continue before the US District Court for the Northern District of Illinois, according to a statement from Dabur on Wednesday.
Dabur International and Dermoviva were removed and got relief in the multiple suits due to lack of jurisdiction as they have not either manufactured, marketed, distributed or sold hair relaxer products in the US, it added.
Three foreign subsidiaries of Dabur India — Namaste Laboratories LLC, Dermoviva Skin Essentials Inc and Dabur International Ltd — were facing approximately 5,400 cases in the federal and state courts in the US, which was later consolidated to the Northern District of Illinois, the company had last month disclosed in a regulatory filing.
«We wish to inform that Dabur and Dermoviva have been dismissed as defendants in federal cases, which were consolidated as a Multi-District Litigation, before the US District Court for the Northern District of Illinois, for lack of personal jurisdiction as neither Dabur nor Dermoviva manufactured, marketed, distributed or sold hair relaxer products in the US,» said Dabur India on Wednesday.
Hence, now only Namaste remains as a defendant in these cases along with many other industry players such as L'Oreal, SoftSheen/Carson, Luster Products Inc, Avlon Industries, Inc.
PDC Brands (Parfums de Coeur, Ltd), Revlon etc," Dabur added.
The Homegrown FMCG and Ayurvedic products maker further stated that this